Neurosteroids, stress and depression: potential therapeutic opportunities

CF Zorumski, SM Paul, Y Izumi, DF Covey… - Neuroscience & …, 2013 - Elsevier
Neurosteroids are potent and effective neuromodulators that are synthesized from
cholesterol in the brain. These agents and their synthetic derivatives influence the function of …

Neurosteroid actions in memory and neurologic/neuropsychiatric disorders

MH Ratner, V Kumaresan, DH Farb - Frontiers in endocrinology, 2019 - frontiersin.org
Memory dysfunction is a symptomatic feature of many neurologic and neuropsychiatric
disorders; however, the basic underlying mechanisms of memory and altered states of …

Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics

CE Marx, RD Stevens, LJ Shampine… - …, 2006 - nature.com
Evidence suggests that neuroactive steroids may be candidate modulators of schizophrenia
pathophysiology and therapeutics. We therefore investigated neuroactive steroid levels in …

Allopregnanolone in mood disorders: Mechanism and therapeutic development

S Chen, L Gao, X Li, Y Ye - Pharmacological Research, 2021 - Elsevier
The neuroactive steroid allopregnanolone (ALLO) is an endogenous positive allosteric
modulator of GABA type A receptor (GABA AR), and the down-regulation of its biosynthesis …

GABAA receptors and their associated proteins: Implications in the etiology and treatment of schizophrenia and related disorders

EI Charych, F Liu, SJ Moss, NJ Brandon - Neuropharmacology, 2009 - Elsevier
γ-aminobutyric acid type A (GABAA) receptors play an important role in mediating fast
synaptic inhibition in the brain. They are ubiquitously expressed in the CNS and also …

Antidepressant like effect of selective serotonin reuptake inhibitors involve modulation of imidazoline receptors by agmatine

BG Taksande, NR Kotagale, SJ Tripathi, RR Ugale… - …, 2009 - Elsevier
Recent findings demonstrated the dysregulation of imidazoline receptor binding sites in
major depression and their normalization by chronic treatment with antidepressants …

Midazolam inhibits hippocampal long-term potentiation and learning through dual central and peripheral benzodiazepine receptor activation and …

K Tokuda, KA O'Dell, Y Izumi… - Journal of …, 2010 - Soc Neuroscience
Benzodiazepines (BDZs) enhance GABA A receptor inhibition by direct actions on central
BDZ receptors (CBRs). Although some BDZs also bind mitochondrial receptors [translocator …

Effect of co-treatment of olanzapine with SEP-363856 in mice models of schizophrenia

L Liang, X Ren, J Xu, Y Ma, Y Xue, T Zhuang, G Zhang - Molecules, 2022 - mdpi.com
Olanzapine is a commonly used drug in the treatment of schizophrenia, but its clinical
application has been restricted by metabolic-related side effects. In order to mitigate the …

Stress and drug abuse-related disorders: The promising therapeutic value of neurosteroids focus on pregnenolone-progesterone-allopregnanolone pathway

G Tomaselli, M Vallée - Frontiers in Neuroendocrinology, 2019 - Elsevier
The pregnenolone-progesterone-allopregnanolone pathway is receiving increasing
attention in research on the role of neurosteroids in pathophysiology, particularly in stress …

Neurosteroids in schizophrenia: pathogenic and therapeutic implications

HL Cai, T Cao, X Zhou, JK Yao - Frontiers in psychiatry, 2018 - frontiersin.org
Neurosteroids are a group of important endogenous molecules affecting many neural
functions in the brain. Increasing evidence suggests a possible role of these neurosteroids …